Olanzapine Tablets, USP, 10 mg, Rx Only, 30 tablets per bottle, Mfd for: Prasco Laboratories, Mas...
FDA Drug Recall #D-830-2013 — Class II — July 22, 2013
Recall Summary
| Recall Number | D-830-2013 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 22, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Torrent Pharma Inc |
| Location | Kalamazoo, MI |
| Product Type | Drugs |
| Quantity | 18,721 bottles |
Product Description
Olanzapine Tablets, USP, 10 mg, Rx Only, 30 tablets per bottle, Mfd for: Prasco Laboratories, Mason OH, 45040, USA, Mfd by: Torrent Pharmaceuticals Ltd., Indrad-382 721, Dist. Mehsana India, NDC 66993-463-30
Reason for Recall
Defective Container; This action is being taken as a precautionary measure due to the product being re-packaged in the U.S. using a filler material that (removes or blocks) less moisture than what is approved in the application.
Distribution Pattern
Nationwide
Lot / Code Information
Lot #: BS392004A, Exp: 09/2014
Other Recalls from Torrent Pharma Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0852-2022 | Class II | Pantoprazole Sodium Delayed-Release Tablets, US... | Apr 11, 2022 |
| D-0166-2021 | Class I | Anagrelide Capsules, USP 1 mg, 100 capsules, Rx... | Nov 25, 2020 |
| D-1371-2019 | Class II | Nasal Decongestant Liquid, Pseudoephedrine HCl,... | May 21, 2019 |
| D-1367-2019 | Class II | Kid Kare Childrens Cough/Cold Liquid, Antihista... | May 21, 2019 |
| D-1357-2019 | Class II | Biscolax Laxative (Bisacodyl, USP 10 mg), a) 12... | May 21, 2019 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.